Publication | Closed Access

Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia

Cerebral Vascular RegulationStrokeMedicineCerebrovascular DiseaseNeuropharmacologyPolymerase Inhibitor OlaparibVascular BiologyBrain InjuryNeuroprotectionNeurologyNeuroscienceCerebral Blood FlowNeuropathologyPharmacologyAtherosclerosisIschemic SyndromeReperfusion Injury